Antiviral pill reduces hospitalisation and death by 89%


 

The war against Covid-19 may have just gotten easier. Pfizer announced their antiviral pill is shown to reduce hospitalisation and death for those with the disease if taken within three days of the appearance of symptoms.

"Pfizer plans to submit the data to the FDA for emergency approval "as soon as possible" and has stopped enrolling for its clinical trial following strong positive results"

The pill, named Paxlovid, works by inhibiting an enzyme called protease that the virus needs to replicate.

All of the participants in the study had mild to moderate symptoms, had an underlying condition that put them at risk of severe conditions, and were all unvaccinated.

An independent observer group stopped the study after seeing the results so Pfizer could immediately request emergency use from the FDA. For all of the details and results, click the article below.

CLICK HERE FOR THE FULL ORIGINAL ARTICLE



Comments

Popular posts from this blog

Ice cubes that don't melt or get contaminated

This amazing living "robot" can reproduce on its own

Why bugs should be in our diet